Roar! Broker initiates coverage on Liontown shares with buy rating

This lithium share could be a high-risk, high-reward option for investors…

| More on:
A person wears a roaring lion mask.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Liontown Resources Ltd (ASX: LTR) shares are pushing higher in afternoon trade.

At the time of writing, the lithium developer's shares are up over 2% to $1.35.

Why are Liontown shares rising?

Investors appear to have been buying Liontown shares on Tuesday in response to the release of a broker note out of Morgans.

According to the note, the broker has initiated coverage on the lithium developer with a speculative buy rating and $1.96 price target.

Based on its current share price, this implies potential upside of 45% for investors over the next 12 months.

Though, given its speculative rating, it is a high-risk option and thus only suitable for investors with a higher tolerance for risk.

What did the broker say?

Morgans notes that the company is a near-term developer of Australian spodumene and believes there's significant potential upside for Liontown shares if it can resolve its funding issues and avoid further significant cost blowouts. It commented:

LTR is an early stage developer with spodumene assets in central and southern WA. It is currently constructing the Katherine Valley (KV) project. Planned capacity is 3Mtpa – 4Mtpa (ROM tonnes) with first production expected in mid 2024. The KV project is supported by offtake agreements with several tier one customers.

The company and its flagship project have been impacted by cost increases however and additional funding will be required to complete it. We initiate with a SPECULATIVE BUY rating with potential 12-month upside of 44% to our $1.96 price target. However, we see LTR as a higher risk opportunity than its established peers.

The broker's preferred pick in the industry remains Allkem Ltd (ASX: AKE). It has an add rating and $15.40 price target on the lithium giant's shares. It stated:

We continue to prefer AKE amongst the lithium pure plays as we see a longer growth runway for production and greater potential valuation upside.

Motley Fool contributor James Mickleboro has positions in Allkem. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A man slumps crankily over his morning coffee as it pours with rain outside.
Broker Notes

Why Lynas shares could crash 33%

Bell Potter believes this rare earths stock could lose a third of its value.

Read more »

Three girls compete in a race, running fast around an athletic track.
Broker Notes

Two ASX 200 stocks to buy after crashing 6-9% yesterday

Bell Potter is tipping an 18-40% resurgence for these stocks.

Read more »

A woman looks quizzical as she looks at a graph of the share market.
Broker Notes

Looking for double-digit returns? Check out RBC Capital Markets' picks ahead of reporting season

These shares could deliver strong upside.

Read more »

Man controlling a drone in the sky.
Broker Notes

ASX defence stocks to target according to Bell Potter

The bull run might not be finished yet for these two companies.

Read more »

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements
Broker Notes

What is Morgans saying about ARB and BHP shares?

Is now the time to buy these popular shares? Let's find out.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 63% since June, why this ASX All Ords share is tipped to keep outperforming in 2026

A leading broker expects more outsized gains for this ASX All Ords share.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Northern Star, Pro Medicus, and Web Travel shares

How does the team at Morgans rate these popular shares? Let's find out.

Read more »

Contented looking man leans back in his chair at his desk and smiles.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »